35 Fanconi Anemia Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Fanconi Anemia Studies in Rochester

NCT06964464Recruiting

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

This prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure...

Rochester, MN2,000 participantsUniversity of Rochester

View Study Details

NCT04334707Recruiting

Kidney Precision Medicine Project

Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despit...

Rochester, MN1,000 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06271577Recruiting

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

AliveCor (www.alivecor.com) has developed several electrocardiogram (ECG) devices that interface with iOS and Android smartphones and tablets via various Kardia apps. The current Kardia family of devi...

Rochester, MN1,000 participantsAliveCor

View Study Details

NCT05873634Recruiting

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of br...

Rochester, MN1,000 participantsNorthwestern University

View Study Details

NCT04365855Recruiting

The Olmsted NAFLD Epidemiology Study (TONES)

Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults wit...

Rochester, MN800 participantsMayo Clinic

View Study Details

NCT06195059Recruiting

Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume

The purpose of this study is to evaluate whether pulmonary blood volume (PBV) derived from contrast echocardiography can serve as a non-invasive surrogate for invasive pulmonary artery wedge pressure ...

Rochester, MN800 participantsMayo Clinic

View Study Details

NCT06876649Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

Rochester, MN787 participantsEli Lilly and Company

View Study Details

NCT07401771Recruiting

Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea....

Rochester, MN400 participantsMayo Clinic

View Study Details

NCT05122962Recruiting

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with conge...

Rochester, MN300 participantsMayo Clinic

View Study Details

NCT07206602Recruiting

AI-Guided Left Bundle Branch Area Pacing

The purpose of this study is to compare the effectiveness of AI-guided LBBAP versus conventional LBBAP (not AI-guided) in improving CRT response rates and clinical outcomes....

Rochester, MN224 participantsMayo Clinic

View Study Details

NCT07038200Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...

Rochester, MN200 participantsAvidity Biosciences, Inc.

View Study Details

NCT06517186Recruiting

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a ...

Rochester, MN180 participantsNorthwestern University

View Study Details

NCT04592445Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes peo...

Rochester, MN150 participantsAxon Therapies, Inc.

View Study Details

NCT06374875Recruiting

Fibrosis Lessens After Metabolic Surgery

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly associated with obesity...

Rochester, MN120 participantsAli Aminian

View Study Details

NCT04521699Recruiting

Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.

The primary purpose of this study is to determine if there are significant differences with respect to baseline between those randomized to CGo and standard-of-care versus standard-of-care alone after...

Rochester, MN100 participantsMayo Clinic

View Study Details

NCT06432543Recruiting

Polyethylene Wear Particle Analysis of THA

Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and...

Rochester, MN90 participantsOsaka Metropolitan University

View Study Details

NCT06847282Recruiting

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

The primary goal of this study is to validate motor and functional outcomes and refine clinical trial strategies for pediatric-onset FSHD...

Rochester, MN80 participantsUniversity of Kansas Medical Center

View Study Details

NCT07278570Recruiting

Magnetic Resonance Elastography to Monitor Response to Manual Therapy in Myofascial Pain

The purpose of this research is to develop and test new Magnetic Resonance Imaging (MRI) methods that look at how muscles and tissues under the skin (myofascial tissues) move and respond to pressure. ...

Rochester, MN78 participantsMayo Clinic

View Study Details

NCT05551793Recruiting

Regeneron AA Multicenter (Dupilumab)

This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affe...

Rochester, MN76 participantsEmma Guttman

View Study Details

NCT07656259Recruiting

COMPARE-VENT Feasibility Pilot Study

Cardiac disease complicated by respiratory insufficiency comprises the most frequent indication for cardiac intensive care unit (CICU) admission, with nearly one-third patients requiring advanced resp...

Rochester, MN75 participantsMayo Clinic

View Study Details

NCT06874556Recruiting

A Study of Paramedic HF Management

The purpose of this research is to see if having community paramedic (CP) visit patients at home to manage their heart failure help them stay out of the hospital and improve their overall health compa...

Rochester, MN75 participantsMayo Clinic

View Study Details

NCT07086131Recruiting

A Study Investigating the Impact of IMT With CR On Exercise Responses In HF

The purpose of this study is to compare the impact of inspiratory muscle training (IMT) combined with cardiac rehabilitation (CR) on cardiovascular function in patients with heart failure....

Rochester, MN70 participantsMayo Clinic

View Study Details

NCT06566911Recruiting

Voice Analysis for Monitoring Patients With Heart Failure

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during...

Rochester, MN70 participantsNoah Labs

View Study Details

NCT06510231Recruiting

Inspiratory Muscle Training in HFpEF

This study is being done to determine how inspiratory muscle training impacts inspiratory muscle function during exercise in heart failure patients....

Rochester, MN68 participantsMayo Clinic

View Study Details

NCT05552755Recruiting

Evaluate REC-4881 in Patients With FAP

This is a multicenter, two-part trial in participants with Familial Adenomatous Polyposis (FAP)....

Rochester, MN67 participantsRecursion Pharmaceuticals Inc.

View Study Details

NCT06892483Recruiting

Breastmilk in Response to a Bout of Exercise

The purpose of this study is to unveil the mechanistic benefits of a bout of postpartum maternal exercise on infant health that are provided by breastmilk....

Rochester, MN60 participantsMayo Clinic

View Study Details

NCT05465941Recruiting

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

This phase II trial tests whether pegylated SN-38 conjugate PLX038 (PLX038) works to shrink tumors in patients with ovarian, primary peritoneal, and fallopian tube cancers that has spread from where i...

Rochester, MN43 participantsMayo Clinic

View Study Details

NCT06360380Recruiting

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps...

Rochester, MN40 participantsAquaPass Medical Ltd.

View Study Details

NCT03723564Recruiting

Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia

Congenital lower urinary tract obstruction (LUTO) is a heterogeneous group of congenital anomalies that lead bladder outlet obstruction. If a complete obstruction is present, the perinatal mortality i...

Rochester, MN40 participantsMayo Clinic

View Study Details

NCT06295588Recruiting

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation....

Rochester, MN40 participantsUniversity of Rochester

View Study Details

NCT05919680Recruiting

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with ...

Rochester, MN36 participantsNorthSea Therapeutics B.V.

View Study Details

NCT07083011Recruiting

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

The purpose of this study is to assess the performance of 68Ga- FAPI PET in heart failure with preserved ejection fraction (HFpEF)...

Rochester, MN35 participantsMayo Clinic

View Study Details

NCT06721299Recruiting

Clenbuterol to Target DUX4 in FSHD

The purpose of this study is to determine if Clenbuterol is a therapeutic option for FSHD by determining the safety and tolerability of the medication at three different dose levels....

Rochester, MN30 participantsJeffrey Statland

View Study Details

NCT07093528Recruiting

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)...

Rochester, MN25 participantsMayo Clinic

View Study Details

NCT06702501Recruiting

The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)

The PeriCut early feasibility study will evaluate the safety and feasibility of successfully performing a minimally invasive pericardiotomy in patients with heart failure with preserved ejection fract...

Rochester, MN10 participantsHeart Failure Solutions, Inc.

View Study Details

About Fanconi Anemia Clinical Trials in Rochester

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 35 fanconi anemia clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 10,169 participants. Research is being sponsored by University of Rochester, Icahn School of Medicine at Mount Sinai, AliveCor and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in Rochester — FAQ

Are there fanconi anemia clinical trials in Rochester?

Yes, there are 35 fanconi anemia clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 35 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov